Work

Abstract 4364: Preclinical pharmacokinetics and pharmacodynamics of MK-4464, a novel NK cell engager targeting CEACAM5

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-4364

Authors: Tapan Nayak, Yanyan Zheng, Li Li, Sophie Li, Smita Mauze, Mingmei Cai, Ruban Mangadu, Kerry Riffel, Xiangjun Meng, SuChun Hseih, Konstantin Dobrenkov, Amy Beebe

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Immune Cell Function and Interaction

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409633144

Cites:

Cited by: 1

Related to: 10